Throat Lozenges Market to grow at a CAGR of 4.92% during 2025 to 2035; Driven by Rising Prevalence of Respiratory Infections and Growing Demand for Over-the-Counter Remedies

Market Highlights

Global Throat Lozenges Market Size was valued at USD 4.93 Billion in 2024 & the market is projected to grow from USD 5.173 Billion in 2025 to USD 8.362 Billion by 2035, registering a CAGR of 4.92% during the forecast period 2025–2035.

The Throat Lozenges Market is currently undergoing dynamic evolution, driven by increasing awareness of throat health, rising incidence of respiratory conditions, and a strong consumer shift toward self-care and over-the-counter remedies. Upper respiratory infections continue to affect hundreds of millions of people annually, creating sustained demand for convenient, symptomatic relief solutions.

Key growth drivers include expanding retail and e-commerce channels, seasonal demand surges during colder months, heightened self-care practices, product formulation innovations, and the rising prevalence of throat disorders. Global internet penetration exceeding 68% has accelerated online sales of healthcare products, which are growing at over 8% annually. Additionally, PubMed research indicates that over 70% of adults use over-the-counter products to manage common minor ailments, while over 60% of global consumers now prefer natural or plant-based remedies containing ingredients such as honey, ginger, and menthol.

Regulatory frameworks and body guidelines across major regions continue to foster product safety, quality, and clinical innovation. Health authorities such as the FDA in North America and the European Medicines Agency (EMA) support streamlined approval processes for over-the-counter products, encouraging manufacturers to introduce sugar-free, organic, and multifunctional lozenge formulations to the global market.

The key players recognized by MRFR operating in the Throat Lozenges Market include global healthcare leaders such as Reckitt Benckiser (GB), Procter & Gamble (US), Pfizer (US), Bayer (DE), and GlaxoSmithKline (GB). The market is also supported by prominent industry participants, including Haleon (GB), Church & Dwight (US), and MediNatura (DE).

Segment Analysis

The Global Throat Lozenges Market is segmented by type, ingredient, indication, and region.

By type, the market is segmented into Hard Candy Lozenges, Soft Lozenges, and Compressed Lozenges. The Hard Candy Lozenges segment dominates the market, accounting for a significant 58% share in 2024 due to long-standing consumer familiarity, proven effectiveness, and broad retail availability. Meanwhile, Soft Lozenges represent the fastest-growing segment, rapidly gaining traction among health-conscious consumers seeking alternative formats.

Based on ingredient, the market is divided into Menthol, Mint, Eucalyptus Oil, Peppermint Oil, Honey & Ginger, Lemon, and Others. Menthol-based formulations hold the largest share, accounting for nearly 46% of ingredient segment revenue in 2024, driven by widespread therapeutic acceptance and soothing properties. Honey & Ginger represents the fastest-growing segment, appealing strongly to consumers seeking natural and herbal throat care remedies.

By indication, the market is segmented into Sore Throat, Cough and Cold, and Throat Diseases. Sore Throat applications dominate the segment, accounting for approximately 55% of market demand in 2024, driven by the high prevalence of throat irritation. Cough and Cold represents the fastest-growing segment, driven by increasing consumer demand for multi-symptom relief solutions during seasonal illness peaks.

Regional Analysis

Regionally, the Global Throat Lozenges Market is segmented into North America, Europe, Asia-Pacific, and the Middle East and Africa.

North America leads in the Throat Lozenges Market Size, accounting for over 40.57% of the global revenue in 2024. Sustained demand in the US and Canada is driven by high rates of upper respiratory physician visits, strong health awareness, and FDA regulatory support.

Europe Throat Lozenges Market size was valued at USD 1.48 Billion in 2024, making it the second-largest regional market with a 30% share. Market expansion in Germany and the UK is supported by an aging population, robust e-commerce distribution, and European Medicines Agency regulatory standards.

Asia-Pacific is emerging as a significant player in the throat lozenges market, accounting for about 25% of the global share. Growth in China and India is fueled by rising disposable incomes, expanding internet infrastructure, and strong consumer preference for herbal and natural lozenge formulations.

The Middle East and Africa region represents a smaller segment of the throat lozenges market, holding approximately 5% of the global share. Market growth in South Africa and the UAE is driven by expanding urban populations, increasing healthcare expenditure, and rising availability across retail channels.

Key Findings of the Study

• North America accounted for over 40.57% of global Throat Lozenges Market revenue in 2024, maintaining the leading regional position.


• Europe generated USD 1.48 billion in revenue during 2024, representing approximately 30.02% of the global market.


• Hard Candy Lozenges accounted for approximately 58% of total market revenue in 2024, maintaining leadership through strong consumer preference.


• Menthol-based formulations generated nearly 46% of ingredient segment revenue in 2024, supported by widespread therapeutic acceptance.